Frida Nyberg
Overview
Explore the profile of Frida Nyberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Handin N, Mickols E, Olander M, Rudfeldt J, Blom K, Nyberg F, et al.
iScience
. 2021 Nov;
24(11):103235.
PMID: 34746700
Spheroid cultures of primary human hepatocytes (PHH) are used in studies of hepatic drug metabolism and toxicity. The cultures are maintained under different conditions, with possible confounding results. We performed...
2.
Niklasson M, Bergstrom T, Jarvius M, Sundstrom A, Nyberg F, Haglund C, et al.
J Pathol
. 2019 Jul;
249(3):295-307.
PMID: 31298733
Grade IV astrocytoma/glioblastoma multiforme (GBM) is essentially incurable, partly due to its heterogenous nature, demonstrated even within the glioma-initiating cell (GIC) population. Increased therapy resistance of GICs is coupled to...
3.
Nazir M, Senkowski W, Nyberg F, Blom K, Edqvist P, Jarvius M, et al.
Exp Cell Res
. 2017 Nov;
361(2):308-315.
PMID: 29107068
We and others have previously reported a correlation between high phosphodiesterase 3A (PDE3A) expression and selective sensitivity to phosphodiesterase (PDE) inhibitors. This indicates that PDE3A could serve both as a...
4.
Segerman A, Niklasson M, Haglund C, Bergstrom T, Jarvius M, Xie Y, et al.
Cell Rep
. 2016 Dec;
17(11):2994-3009.
PMID: 27974212
Intratumoral heterogeneity is a hallmark of glioblastoma multiforme and thought to negatively affect treatment efficacy. Here, we establish libraries of glioma-initiating cell (GIC) clones from patient samples and find extensive...
5.
Punga A, Alimohammadi M, Fagrell D, Nyberg F, Rees D, Wong C
Dermatol Surg
. 2016 Jul;
42(8):967-76.
PMID: 27399956
Background: Different volumes of 0.9% NaCl may be used to reconstitute abobotulinumtoxinA yielding an injection volume that ranges from 0.05 to 0.1 mL per injection point for treatment of glabellar...